Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation

Yongping Mu(Shanghai University of Traditional Chinese Medicine), Ping Liu(Shanghai University of Traditional Chinese Medicine), Xiao Zhang(Henan Academy of Sciences), Hua Zhang(Shanghai University of Traditional Chinese Medicine), Jiamei Chen(Shanghai University of Traditional Chinese Medicine), LI Xue-wei(Shanghai University of Traditional Chinese Medicine), Weiwei Fan(Shanghai University of Traditional Chinese Medicine), Gaofeng Chen(Henan University of Technology), Chenghai Liu(Shanghai University of Traditional Chinese Medicine)
Journal of Ethnopharmacology
April 25, 2015
10.1016/j.jep.2015.04.015
Cited by 42

Related Papers

Pharmacological effects of Astragaloside IV: a literature review
|中医杂志：英文版|2013|263
Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage
|Frontiers in Pharmacology|2020|176
Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review
|Frontiers in Pharmacology|2022|96
Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine–choline-deficient diet
|Laboratory Investigation|2009|77
Inhibition of notch signaling pathway prevents cholestatic liver fibrosis by decreasing the differentiation of hepatic progenitor cells into cholangiocytes
|Laboratory Investigation|2015|75